Vanda Pharmaceuticals | Cassa E Equivalenti

Cash And Equivalent Cambiamento Data
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Arrowhead Research USD 58.22M 44.78M 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Insmed USD 482.37M 4.74M 2023-12
Ligand Pharmaceuticals USD 22.95M 3.68M 2023-12
Moderna USD 2.91B 25M 2023-12
Pfizer USD 3.15B 516M 2023-09
Takeda JPY 318.05B 1.67B 2023-09
Teva Pharmaceutical Industries USD 2.25B 420M 2023-09
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Veracyte USD 216.45M 13.99M 2023-12



Vanda Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.